Revvity Operating Income 2010-2024 | RVTY
Revvity annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Revvity operating income for the quarter ending March 31, 2024 was $0.044B, a 42.04% decline year-over-year.
- Revvity operating income for the twelve months ending March 31, 2024 was $0.269B, a 51.77% decline year-over-year.
- Revvity annual operating income for 2023 was $0.301B, a 59.53% decline from 2022.
- Revvity annual operating income for 2022 was $0.743B, a 40.98% decline from 2021.
- Revvity annual operating income for 2021 was $1.258B, a 45.11% increase from 2020.
| Revvity Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $301 |
| 2022 | $743 |
| 2021 | $1,258 |
| 2020 | $867 |
| 2019 | $362 |
| 2018 | $324 |
| 2017 | $296 |
| 2016 | $295 |
| 2015 | $251 |
| 2014 | $165 |
| 2013 | $228 |
| 2012 | $103 |
| 2011 | $91 |
| 2010 | $158 |
| 2009 | $116 |
| Revvity Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $44 |
| 2023-12-31 | $77 |
| 2023-09-30 | $69 |
| 2023-06-30 | $78 |
| 2023-03-31 | $76 |
| 2022-12-31 | $137 |
| 2022-09-30 | $111 |
| 2022-06-30 | $232 |
| 2022-03-31 | $262 |
| 2021-12-31 | $263 |
| 2021-09-30 | $196 |
| 2021-06-30 | $332 |
| 2021-03-31 | $468 |
| 2020-12-31 | $399 |
| 2020-09-30 | $248 |
| 2020-06-30 | $176 |
| 2020-03-31 | $45 |
| 2019-12-31 | $138 |
| 2019-09-30 | $79 |
| 2019-06-30 | $92 |
| 2019-03-31 | $53 |
| 2018-12-31 | $116 |
| 2018-09-30 | $80 |
| 2018-06-30 | $88 |
| 2018-03-31 | $40 |
| 2017-12-31 | $94 |
| 2017-09-30 | $78 |
| 2017-06-30 | $74 |
| 2017-03-31 | $50 |
| 2016-12-31 | $92 |
| 2016-09-30 | $76 |
| 2016-06-30 | $66 |
| 2016-03-31 | $61 |
| 2015-12-31 | $50 |
| 2015-09-30 | $76 |
| 2015-06-30 | $68 |
| 2015-03-31 | $57 |
| 2014-12-31 | $-15 |
| 2014-09-30 | $59 |
| 2014-06-30 | $70 |
| 2014-03-31 | $52 |
| 2013-12-31 | $94 |
| 2013-09-30 | $58 |
| 2013-06-30 | $40 |
| 2013-03-31 | $36 |
| 2012-12-31 | $-26 |
| 2012-09-30 | $43 |
| 2012-06-30 | $50 |
| 2012-03-31 | $36 |
| 2011-12-31 | $-26 |
| 2011-09-30 | $36 |
| 2011-06-30 | $39 |
| 2011-03-31 | $41 |
| 2010-12-31 | $52 |
| 2010-09-30 | $41 |
| 2010-06-30 | $33 |
| 2010-03-31 | $31 |
| 2009-12-31 | $31 |
| 2009-09-30 | $22 |
| 2009-06-30 | $38 |
| 2009-03-31 | $25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.191B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.903B | 15.80 |
| Cencora (COR) | United States | $47.741B | 18.61 |
| ICON (ICLR) | Ireland | $26.139B | 24.68 |
| DiDi Global (DIDIY) | China | $21.386B | 0.00 |
| Avantor (AVTR) | United States | $15.283B | 22.50 |
| CochLear (CHEOY) | Australia | $14.173B | 0.00 |
| Natera (NTRA) | United States | $13.190B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.644B | 41.60 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| Charles River Laboratories (CRL) | United States | $10.809B | 20.69 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.137B | 0.00 |
| Solventum (SOLV) | United States | $8.860B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.681B | 0.00 |
| HealthEquity (HQY) | United States | $7.198B | 46.21 |
| Organon (OGN) | United States | $5.431B | 5.15 |
| Bausch + Lomb (BLCO) | Canada | $5.256B | 21.04 |
| Doximity (DOCS) | United States | $5.107B | 35.77 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.623B | 37.96 |
| Sotera Health (SHC) | United States | $3.369B | 16.53 |
| Surgery Partners (SGRY) | United States | $3.017B | 27.60 |
| GoodRx Holdings (GDRX) | United States | $2.859B | 108.86 |
| Agilon Health (AGL) | United States | $2.677B | 0.00 |
| Progyny (PGNY) | United States | $2.487B | 42.82 |
| AMN Healthcare Services Inc (AMN) | United States | $2.029B | 8.04 |
| NovoCure (NVCR) | Jersey | $2.014B | 0.00 |
| Premier (PINC) | United States | $1.949B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.852B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.757B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| CareDx (CDNA) | United States | $0.749B | 0.00 |
| Embecta (EMBC) | United States | $0.722B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.695B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.680B | 7.21 |
| Auna S.A (AUNA) | Luxembourg | $0.568B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.430B | 0.00 |
| Enhabit (EHAB) | United States | $0.426B | 42.50 |
| ModivCare (MODV) | United States | $0.367B | 6.87 |
| Sonida Senior Living (SNDA) | United States | $0.345B | 0.00 |
| DocGo (DCGO) | United States | $0.310B | 16.94 |
| LifeMD (LFMD) | United States | $0.288B | 0.00 |
| MultiPlan (MPLN) | United States | $0.238B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.49 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| Co-Diagnostics (CODX) | United States | $0.043B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.035B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |